目次

Table of Contents

I. Introduction

II. Market Overview

III. Major Product Development Opportunities

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

VI. Potential Market Entry Barriers and Risks

VII. Major Current and Emerging Cancer Diagnostic Tests
　1. Introduction
　2. Cancer Diagnostic Classification
　3. ACTH
　4. Alpha-Fetoprotein (AFP)
　5. Beta-2 Microglobulin
　6. CA 15-3/27.29
　7. CA 19-9
　8. CA-125
　9. Calcitonin
　10. Carcinoembrionic Antigen (CEA)
　11. Estrogen and Progesterone Receptors
　12. Ferritin
　13. Gastrin
　14. Human Chorionic Gonadotropin (HCG)
　15. Insulin
　16. NSE
　17. Occult Blood
　18. PAP Smear/HPV
　19. Prostatic Acid Phosphatase (PAP)
　20. Prostate-Specific Antigen (PSA)
　21. Squamous Cell Carcinoma Antigen (SCC)
　22. T and B Lymphocytes
　23. TdT
　24. Thyroglobulin
　25. Tissue Polypeptide Antigen (TPA)
　26. Biochemical Cancer Diagnostics
　27. Oncogenes
　　　- Abl/abl-bcr
　　　- AIB1
　　　- BCL-2
　　　- BRCA1
　　　- CD44
　　　- C-fos
　　　- C-myb
　　　- C-myc
　　　- CYP-17
　　　- Erb-B
　　　- HPC1
　　　- N-myc
　　　- P40
　　　- P51
　　　- P53
　　　- PIK3CA
　　　- PTI-1
　　　- Ras
　　　- Reg
　　　- Sis
　　　- Src and others
　28. Polypeptide Growth Factors
　　　- Basic Fibroblast Growth Factor
　　　- Beta-TGF
　　　- Cachectin (TNT)
　　　- Calmodulin
　　　- ECFR
　　　- Nerve Growth Factor (NGF)
　　　- Epidermal Growth Factor (EGF)
　　　- Ornithine Decarboxylase
　　　- Transferrin
　　　- Transforming Growth Factor-Alpha
　29. Ectopic Hormones
　30. Colony Stimulating Factors
　31. Lymphokines
　　　- Alpha-Interferon
　　　- B Cell Growth Factors
　　　- B Cell Growth Factor (BCGF)
　　　- Gamma-Interferon
　　　- Interleukin-1 (IL-1)
　　　- Macrophage Activating Factor
　32. Immunohistochemical Stains
　33. Emerging Cancer Diagnostics
　　　- N-Acetylglucosamine
　　　- Actin
　　　- Alpha-Actin
　　　- Antineuronal Antibodies
　　　- 7B2
　　　- B72.3
　　　- Bax
　　　- BCD-F9
　　　- BLCA-4
　　　- Blood Group Antigens A,B,H
　　　- CA 50
　　　- CA 72-4/TAG-72
　　　- CA 195
　　　- CA-242
　　　- CA-549
　　　- CAM 26
　　　- CAR-3
　　　- Cathepsin-D
　　　- Chromogranin A and B
　　　- Cluster 1 Antigen
　　　- Cluster-5/5A Antigen
　　　- CTA
　　　- CU18
　　　- DR-70
　　　- DU-PAN-2
　　　- Endometrial Bleeding Associated Factor
　　　- Endostatin
　　　- Epithelial Membrane Antigen
　　　- Feulgen Hydrolysis
　　　- Fibronectin
　　　- FSH
　　　- (1->3)-L-fucosyltransferase
　　　- Gastrin-Releasing Peptide (GRP)
　　　- GDCFP-15
　　　- Glucagon
　　　- Glycoamines
　　　- H23
　　　- Her-2
　　　- Human Carcinoma Antigen
　　　- HPA
　　　- HSP27
　　　- Intermediate Filaments
　　　- Cytokeratins/CK18/Cyfra 21-1
　　　- Desmin
　　　- Gliofibrillary Acid Protein
　　　- Neurofilaments
　　　- Vimentin
　　　- KA 93
　　　- Kinases
　　　- KP16D3
　　　- LAI
　　　- Leukocyte Common Antigen
　　　- Lewis Antigens
　　　- Lysophosphatidic Acid (LPA)
　　　- Ma 695/Ma 552
　　　- MABDF3
　　　- MAG
　　　- ME1
　　　- Minactivin
　　　- MN/CA9
　　　- MSA
　　　- Mucin Cancer Antigen (MCA)
　　　- Multiple Tumor Suppressor 1
　　　- Myosin
　　　- NEA-130
　　　- NMP22
　　　- OA-519
　　　- Opiod Peptides
　　　- P-glycoprotein
　　　- Pancreatic Oncofetal Antigen (POA)
　　　- Placental Lactogen
　　　- PR92
　　　- Proliferative Index, Ki-67
　　　- Px
　　　- RB Inactivation/Deletion
　　　- Ret
　　　- SCCL 175
　　　- Selectin
　　　- Sialic Acid
　　　- Sialyl SSEA-1/SLX
　　　- SN10
　　　- Somatostatin
　　　- TA-90
　　　- TABA
　　　- Tachykinin
　　　- TAG 12
　　　- TPS
　　　- Troponin
　　　- Tubulin
　　　- VCAM
　　　- VEGF
　　　- Villen and others

VIII. Instrumentation Review and Market Needs

IX. Current and Emerging Technologies
　1. Monoclonal and Polyclonal Antibodies
　2. Immunoassays
　3. Molecular Diagnostics
　4. Chromosome Analysis
　　a. Chronic Myelogenous Leukemia (CML)
　　b. Acute Myeloid Leukemia (AML)
　　c. Acute Lymphoblastic Leukemia (ALL)
　　d. Malignant Lymphomas Lymphoid Malignancies
　　e. Chronic Lymphocytic Leukemia (CLL)
　　f. Solid Cancers
　　g. Chromosomal Translocation and Oncogenes
　5. Artificial Intelligence
　6. Flow Cytometry
　7. Two Dimensional Gel Electrophoresis (2-DGE)
　8. Biosensors
　9. Competing/Complementing Technologies

X. Market Size, Test Volume and Sales Forecasts

XI. Competitive Profiles
The report provides strategic assessments of over 30 leading cancer diagnostics market players and start-up companies with innovative technologies and products, including:
　- Abbott
　- Affymetrix
　- Beckman Coulter/Danaher/Cepheid
　- Becton Dickinson
　- bioMerieux
　- Bio-Rad
　- DiaSorin
　- Eiken Chemical
　- Elitech Group
　- Enzo Biochem
　- Fuifilm Wako
　- Fujirebio
　- Grifols
　- Hologic
　- Leica Biosystems
　- Ortho-Clinical Diagnostics
　- PerkinElmer
　- Qiagen
　- Roche
　- Siemens Healthineers
　- Takara Bio
　- Thermo Fisher and others.

List of Tables
Cancer Diagnostic Test Volume and Sales Forecasts
Cancer Diagnostic Volume Forecast by Test
Cancer Diagnostics Sales Forecast by Test
ACTH Test Volume and Diagnostics Sales Forecast
AFP Test Volume and Diagnostics Sales Forecast
Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast
CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast
CA 19-9 Test Volume and Diagnostics Sales Forecast
CA-125 Test Volume and Diagnostics Sales Forecast
Calcitonin Test Volume and Diagnostics Sales Forecast
Cathepsin Test Volume and Diagnostics Sales Forecast
CEA Test Volume and Diagnostics Sales Forecast
Chromogranin Test Volume and Diagnostics Sales Forecast
Colon-specific Antigen Test Volume and Diagnostics Sales Forecast
Cytokeratins Test Volume and Diagnostics Sales Forecast
Estrogen Receptor Test Volume and Diagnostics Sales Forecast
Ferritin Test Volume and Diagnostics Sales Forecast
Gastrin Test Volume and Diagnostics Sales Forecast
HCG Test Volume and Diagnostics Sales Forecast
Insulin Test Volume and Diagnostics Sales Forecast
Interferons Test Volume and Diagnostics Sales
Interleukins Test Volume and Diagnostics Sales Forecast
Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast
NSE Test Volume and Diagnostics Sales Forecast
Nucleolar Test Volume and Diagnostics Sales Forecast
Occult Blood Test Volume and Diagnostics Sales Forecast
Oncogenes Test Volume and Diagnostics Sales Forecast
Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast
PAP Smear Test Volume and Diagnostics Sales Forecast Parathyroid
Hormone Test Volume and Diagnostics Sales Forecast Progesterone
Receptor Test Volume and Diagnostics Sales Forecast PAP Test
Volume and Diagnostics Sales Forecast
PSA Test Volume and Diagnostics Sales Forecast
S-100 Protein Test Volume and Diagnostics Sales Forecast
Serotonin Test Volume and Diagnostics Sales Forecast
Sialic Acid Test Volume and Diagnostics Sales Forecast
Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast
TDT Test Volume and Diagnostics Sales Forecast
Thymidine Kinase Test Volume and Diagnostics Sales Forecast
Thyroglobulin Test Volume and Diagnostics Sales Forecast
TPA Test Volume and Diagnostics Sales Forecast
Cancer Diagnostic Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Sub-classification Tests
Biochemical Markers Potential Applications in Cancer Diagnosis
Oncogenes Potential Applications in Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications in Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications in Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis